Venture Capital Warms to European Biotechs

Private biotech companies globally raised almost $1.3 billion through venture capital deals in the second quarter, up 190 percent from Q1, and European biotechs grabbed 44 percent of that total, according to a report.

ManagersNorth AmericaUSBriefs